Orange Book product · Brand (NDA)
PAXIL
PAROXETINE HYDROCHLORIDE
At a glance
Oct 09, 1998
Approved
Brand (NDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Oct 09, 1998
28 yr 1 mo ago
Today
Pharmaceutical detail
Active ingredient
PAROXETINE HYDROCHLORIDE
Strength
EQ 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage form
CAPSULE
Route
ORAL
TE code
Not listed
Application
NDA 020885
Product number
002
Marketing status
DISCN
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 1999PAXIL CRBrand (NDA)
NDA 020936 · APOTEX
- 1997PAXILBrand (NDA)
NDA 020710 · APOTEX
- 1992PAXILBrand (NDA)
NDA 020031 · APOTEX
- 2026PAROXETINE HYDROCHLORIDEGeneric (ANDA)
ANDA 217280 · ALEMBIC
- 2026PAROXETINE HYDROCHLORIDEGeneric (ANDA)
ANDA 219954 · ANNORA PHARMA
- 2024PAROXETINE HYDROCHLORIDEGeneric (ANDA)
ANDA 209748 · PRINSTON INC
- 2021PAROXETINE HYDROCHLORIDEGeneric (ANDA)
ANDA 211248 · YILING
- 2021PAROXETINE HYDROCHLORIDEGeneric (ANDA)
ANDA 215003 · NOVITIUM PHARMA
- 2021PAROXETINE HYDROCHLORIDEGeneric (ANDA)
ANDA 212645 · CADILA PHARMS LTD
- 2021PAROXETINE HYDROCHLORIDEGeneric (ANDA)
ANDA 213612 · EPIC PHARMA LLC
- 2021PAROXETINE HYDROCHLORIDEGeneric (ANDA)
ANDA 213485 · CSPC OUYI
- 2018PAROXETINE HYDROCHLORIDEGeneric (ANDA)
ANDA 209293 · SCIECURE PHARMA INC
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

